Advertisement
Saturday, Oct 16, 2021
Outlook.com
Outlook.com

Brazil Suspends Covaxin’s Clinical Trials After Bharat Biotech Ends Deal With Precisa Medicamentos

On Friday, Bharat Biotech announced that it cancelled an MoU it signed with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for supply of its Covid-19 vaccine Covaxin, in Brazil.

Brazil Suspends Covaxin’s Clinical Trials After Bharat Biotech Ends Deal With Precisa Medicamentos
A few weeks earlier, authorities in Brazil launched a probe to determine if the Brazilian government paid a higher price for Covaxin | File Photo
Brazil Suspends Covaxin’s Clinical Trials After Bharat Biotech Ends Deal With Precisa Medicamentos
outlookindia.com
2021-07-24T10:15:12+05:30

Brazil on Saturday announced the suspension of Bharat Biotech’s Covaxin trials on its soil after the Hyderabad-based pharmaceutical firm terminated its pact with its Brazilian partner Precisa Medicamentos amid a controversy over suspected irregularities in the deal.

On Friday, Bharat Biotech announced that it has cancelled an MoU it signed with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for supply of its Covid-19 vaccine Covaxin, in Brazil. The firm signed an MoU with the two South American companies on November 20.

A few weeks earlier, authorities in Brazil launched a probe to determine if the Brazilian government paid a higher price for Covaxin and if there were irregularities in the deal. Bharat Biotech has denied any wrongdoing and stated that the global pricing of the vaccine has been set between USD 15-20 and accordingly, the jab was offered to the Government of Brazil at the rate of USD 15 per dose.

"In the Coordination of Clinical Research at Anvisa (Copec/GGMED) determined this Friday (23/7) the precautionary suspension of clinical studies of the Covaxin vaccine in Brazil. The suspension was carried out as a result of a statement from the Indian company Bharat Biotech Limited International, sent to Anvisa on Friday (23/7), Anvisa,” the Brazilian health regulator, said on Friday.

Precisa Medicamentos was Bharat Biotechs partner in Brazil, providing assistance, guidance and support with regulatory submissions, licensure, distribution, insurance and conduct of phase III clinical trials, among others.

Following the graft allegations, the Brazilian government suspended Covaxin's order temporarily.

(With PTI inputs)

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Kashmir Minority Killings A Throwback To The Terrifying 90s

Kashmir Minority Killings A Throwback To The Terrifying 90s

Outwardly peaceful, Kashmir has seen a spate of civilian killings in recent weeks. A silent unease has now exploded into fear and concern after the shooting of minorities.

CWC Meet Begins, Key Decisions On Party's Revamp, Election Of New Chief On The Cards

CWC Meet Begins, Key Decisions On Party's Revamp, Election Of New Chief On The Cards

The Congress Working Committee will deliberate over key issues including organisational elections, forthcoming assembly polls and the current political situation.

Dravid All Set To Become Head Coach Of Indian Cricket Team

Dravid All Set To Become Head Coach Of Indian Cricket Team

He has been in charge of the India A and U-19 set-up for the past six years and a lot of players have come through the system prepared by him.

Lynching, Chopping Off Hand Was 'Punishment' For 'Desecrating' Holy Book: Nihang

Lynching, Chopping Off Hand Was 'Punishment' For 'Desecrating' Holy Book: Nihang

A man wearing the blue robes of the Sikhs’ Nihang order appeared before the media, claiming that he had 'punished' the victim for 'desecrating' a holy book.

Advertisement